U.S. markets close in 3 hours 2 minutes
  • S&P 500

    4,579.03
    +27.35 (+0.60%)
     
  • Dow 30

    35,616.56
    +125.87 (+0.35%)
     
  • Nasdaq

    15,380.75
    +144.91 (+0.95%)
     
  • Russell 2000

    2,285.95
    +33.46 (+1.49%)
     
  • Crude Oil

    81.98
    -0.68 (-0.82%)
     
  • Gold

    1,803.50
    +4.70 (+0.26%)
     
  • Silver

    24.15
    -0.05 (-0.19%)
     
  • EUR/USD

    1.1684
    +0.0077 (+0.67%)
     
  • 10-Yr Bond

    1.5640
    +0.0350 (+2.29%)
     
  • GBP/USD

    1.3790
    +0.0048 (+0.35%)
     
  • USD/JPY

    113.4340
    -0.3760 (-0.33%)
     
  • BTC-USD

    61,212.17
    +2,190.15 (+3.71%)
     
  • CMC Crypto 200

    1,478.89
    +59.51 (+4.19%)
     
  • FTSE 100

    7,249.47
    -3.80 (-0.05%)
     
  • Nikkei 225

    28,820.09
    -278.15 (-0.96%)
     

Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference

  • Oops!
    Something went wrong.
    Please try again later.
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 21st Annual Global Investment Conference, being held September 8-10, 2019, in New York City.

Bellerophon Presentation Details

Date:

Tuesday, September 10, 2019

Time:

2:10 – 2:35 PM ET

Webcast:

http://wsw.com/webcast/hcw5/blph/

About Bellerophon
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. For more information, please visit www.bellerophon.com.

Contacts

At Bellerophon:

At LifeSci Advisors:

Fabian Tenenbaum, Chief Executive Officer

Brian Ritchie

(908) 574-4767

(212) 915-2578

britchie@lifesciadvisors.com